Spinal muscular atrophy outcome measures
Spinal Muscular Atrophy Microchapters
Spinal muscular atrophy outcome measures Resources
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us  to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
There is currently no cure for spinal muscular atrophy. There has been great interest in identifying agents that can increase the amount of full- length SMN protein by upregulating expression of the SMN2 gene. Many clinical trials are ongoing to find the most reliable outcome measures.
Several new outcome measures have shown encouraging results and helped in designing future clinical trials. Some of them currently used in clinical trials are as follows –
- Quantitative muscle ultrasound
- The Six-Minute Walk Test (6MWT) – In case of ambulatory SMA patients.
- 10 minute walk/run test
- The Hammersmith Motor Scale
- The Hammersmith Functional Motor Scale Expanded (HFMSE)
- Knee flexor strength test
- The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)
- The Gross Motor Function Measurement
- Motor unit number estimation (MUNE)
- Compound motor action potential (CMAP) amplitude
- Serologic biomarkers (SMN mRNA and protein levels)